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Here we describe the establishment and prediction utilities for a novel nine-amino-acid transactivation domain, 9aa TAD, that is common to the
transactivation domains of a large number of yeast and animal transcription factors. We show that the 9aa TAD motif is required for the function of
the transactivation domain of Gal4 and the related transcription factors Oaf1 and Pip2. The 9aa TAD possesses an autonomous transactivation
activity in yeast and mammalian cells. Using sequence alignment and experimental data we derived a pattern that can be used for 9aa TAD
prediction. The pattern allows the identification of 9aa TAD in other Gal4 family members or unrelated yeast, animal, and viral transcription
factors. Thus, the 9aa TAD represents the smallest known denominator for a broad range of transcription factors. The wide occurrence of the 9aa
TAD suggests that this domain mediates conserved interactions with general transcriptional cofactors. A computational search for the 9aa TAD is
available online from National EMBnet-Node Austria at http://www.at.embnet.org/toolbox/9aatad/.
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doi:10.1016/j.ygeno.2007.02.003chromatin-modifying and -remodeling enzymes, to facilitating
the assembly of transcription initiation complexes [1–3]. In most
of these protein-protein interactions the transactivation domain
(TAD) of the transcription factors plays a fundamental role. Over
the years, the characterization of TADs has been the subject of
many studies fromwhich several common features have emerged
[4–14]. Apparently, only a limited number of protein-protein
interaction modules are used to orchestrate the TAD-mediated
assembly of the transcription machinery. The frequently used
structural elements of the interacting domains can be brought
about by different amino acids. For this reason the amino acid
sequence of these structural elements is not well conserved.
757S. Piskacek et al. / Genomics 89 (2007) 756–768Consequently, it is difficult to predict the position of an
interaction module in a given protein. For example, acidic and
hydrophobic amino acids were found to be critical for
transactivation by a number of transcription factors (e.g.
VP16, Gal4, Gcn4, and NF-κB). However, the sequence of the
TADs of these particular transcription factors is very diverse [4–
12]. Several transcription factors have been found to interact
with the common transcriptional cofactors of the initiation
complex TFIID, which is composed of the TATA-binding
protein (TBP) and the TBP-associated factors (TAFs) [15–22].
The transcription factors VP16, p53, HSF1, NF-IL6, NF-κB,
and NFAT1 interact directly with the general transcriptional
cofactor TAF9 (TAFII31), a component of the TFIID, SAGA,
PCAF, and TFTC complexes [1–3]. As such, these transcription
factors represent a group of transcription factors whose TADs
are recognized by TAF9. The precise nature of the recognition of
these TADs by TAF9 remains largely elusive. It was reported
that five amino acids (FSDLW) of p53 and four amino acids
(DFEFEQMFTDALGID, the reported amino acids are in bold)
of VP16 are involved in the interaction with TAF9 [1–3].
However, it is not known whether within the TADs of the TAF9-
binding transcription factors there is a common motif that is
recognized by TAF9.
In this study, we have identified a short nine-amino-acid-
long pattern that is common to the transactivation domains of
many diverse yeast and animal transcription factors. This nine-
amino-acid pattern was termed 9aa TAD since it is required for
the transactivation function of several prototype transcription
factors and possesses an autonomous transactivation activity in
both yeast and mammalian cells. To derive the 9aa TAD
pattern we first experimentally determined the minimal
sequence required for transcriptional activity of the yeast
transcription factor Oaf1. A similar sequence was subsequently
found in the Oaf1 orthologs and the Gal4 family of
transcription factors. Multiple sequence alignment of these
related 9aa TAD sequences revealed a pattern that can be used
for computational prediction analysis in yeast protein
sequences and, after minor changes, in animal proteins. The
prediction accuracy was verified on a number of unrelated
yeast and animal transcription factors that contain a well-
characterized TAD. Many of these transcription factors are
known to bind the general transcriptional cofactor TAF9. Thus,
9aa TAD may represent a common motif that is recognized by
TAF9. These data suggest that the 9aa TAD is a universally
recognized transactivation domain that is conserved from yeast
to human. The 9aa TAD prediction service is available online
at the National EMBnet Node Austria Web site: http://www.at.
embnet.org/toolbox/9aatad/.
Results
Minimal transactivation sequence of Oaf1
In our previous study, an essential TAD consisting of 27
amino acid residues was defined within the C-terminal region
of the transcription factor Oaf1 [23]. To delineate the minimal
sequence required for transactivation, we generated N-terminaland C-terminal truncations of the Oaf1 transactivation domain
as well as point mutations. The constructs were tested for
transactivation using LexA fusion in a yeast one-hybrid system
(Fig. 1). A deletion of 11 C-terminal amino acids from the full-
length Oaf1 (construct B101, amino acids 1-1036, Fig. 1A)
caused a complete loss of transactivation. Acidic amino acids
play an essential role in the function of many TADs [4–8,10–
12,24,25]. To find out whether Oaf1 function depends on acidic
residues as well, a region of the Oaf1 TAD containing 2
aspartic residues was substituted by glycines (DYD1037GGG
in construct B103, amino acids 1-1047). Similar to the C-ter-
minal deletion, this substitution mutant displayed no detectable
activity (Fig. 1A).
To exclude the influence of the large Oaf1 regulatory region
[26] on the activity of the Oaf1 TAD in one-hybrid assays, the
deletion and substitution constructs were also generated using
the construct B6 (amino acids 1021-1047), which contained
solely the previously characterized 27-amino-acid TAD. The
deletion of 11 C-terminal amino acids resulted in the construct
B11 (amino acids 1021-1036) and the substitution of DYD by
GGG gave rise to the construct B10. Both the C-terminal
deletion construct B11 and the substitution mutant B10 lost
activity compared to the control (construct B6, Fig. 1). To
characterize further the minimal sequence required for transac-
tivation, we generated additional N-terminal and C-terminal
truncations of the Oaf1 TAD (construct B6, Fig. 1B). The
deletion of 10 N-terminal amino acids (construct B18, amino
acids 1031-1047) resulted in a reduced but still robust activity
(Fig. 1B). Similarly, a deletion of additional 4 amino acids
(construct B12) did not further reduce the activity. The construct
B12 contains a triple-asparagine spacer (NNN) between the
LexA part and the Oaf1 sequence to reduce the influence of
LexA on the TAD. This construct was subjected to N-terminal
truncation analysis. The analysis of the consecutive N-terminal
truncations (constructs B19, B13, and B14) revealed that a
minimal 9-amino-acid-long sequence was required for activity
(Fig. 1B). To find out whether the minimal 9-amino-acid
sequence was conserved we aligned the sequences of Oaf1
orthologs and its close relative Pip2 (Fig. 2A), which all belong
to the Gal4 family of transcription factors. A consensus sequence
was derived for the minimal region that was found to be required
for the transcriptional activity of Oaf1 (the minimal transactivat-
ing sequence of Oaf1, construct B13, Fig. 1B). The amino acid G
(the last amino acid in construct B13, Fig. 1B) was omitted from
the consensus since the alignment with Pip2 revealed this amino
acid not to be conserved. The requirement of this amino acid for
the activity of construct B13 (Fig. 1B) suggests that the core
TAD sequence needs a flanking amino acid that has no sequence
restriction.
To derive a more general pattern suitable for the prediction of
9aa TAD in other transcription factors we made use of the fact
that the distribution of hydrophobic and hydrophilic amino acids
in TADs is of particular importance for transactivation [4–8,10–
12,24,25]. The Oaf1/Pip2 consensus sequence was at each
position supplemented by amino acids with similar hydropho-
bicity values [27]. The amino acids with similar hydrophobicity
values were grouped (Fig. 2B) as follows: (1) group of
Fig. 1. Identification of minimal transactivation domain of Oaf1. (A) Constructs with the Oaf1 transactivation domain (B6, amino acids 1021–1047), Oaf1 lacking 11
C-terminal amino acids (B101, amino acids 1–1036), and the corresponding substitution mutants (B10 and B103, DYD1037GGG) were generated and tested for
transactivation in the one-hybrid system in parallel with the previously described constructs B98, B92, and B96 [23]. (B) Truncations from both N- and C-termini of
the construct B6 containing the 27-amino-acid-long Oaf1 transactivation domain (amino acids 1021–1047) were used for localization of the minimal transactivation
sequence. The deletion of 11 amino acids from the C-terminus (construct B11), truncation from both C- and N-termini leaving only an 8-amino-acid-long sequence
(construct B14), and mutant B10 (with the substitution DYD1037GGG) lack activity. Less extended truncations (constructs B18, B12, B19, and B13) retained
transactivation. The one-hybrid DNA binding domain (LexA), Oaf1 DNA binding domain (DBD), Oaf1 regulatory domain, and transactivation domain (TAD) are
indicated, amino acids in small letters represent substitutions. Values represent β-galactosidase activity of the mutant constructs as a percentage of that of the wild-type
construct B6 (means and plusmn; SD; n=3).
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phobicity value +1.8 or more; (2) narrow group of rather neutral
amino acids G, S, T, W, and Y with hydrophobicity value −0.4
to −1.3 (3) group of slight and medium hydrophilic amino acids
D, E, N, Q,W, and Y with hydrophobicity value and −0.9 to and
−3.5 and (4) broad group of neutral and all hydrophilic amino
acids G, S, T, D, E, N, Q,W, Y, R, K, and H with hydrophobicity
value and −0.4 or less. These groups were used as described
here for the example of position p1 with the consensus amino
acids FLVAD: the amino acids I and M were added since they
complement the Oaf1/Pip2 consensus amino acids F, L, V, and
A in hydrophobicity group 1; the amino acids E, N, Q, W, and Y
were added since they complement the Oaf1/Pip2 consensus
amino acid D in hydrophobicity group 3 (Fig. 2C). The amino
acids from the large group, 4, were used for complementationonly in cases in which amino acids from both group 2 and group
3 were found in the consensus sequence. For this reason, D in
position p1 was complemented only by the amino acids from
group 3 and not group 4. Proline was omitted from the pattern to
avoid structural breaks. For the same reason, glycine was left out
from the internal positions p2-p7. Cysteine was omitted to avoid
S-peptidyl bridging. Thus, the consensus sequence of the Oaf1/
Pip2 TAD ([FLVAD] [FL] [WDE] [FVYE] [FLDE] [FLIY]
[LQG] [FLER]) was extended to the general Oaf1/Pip2 TAD
pattern ([FLIVAMDENQWY] [FLIVAM] [DENQWY] [FLI-
VAMDENQWY] [FLIVAMDENQWY] [FLIVAMSTWY]
[FLIVAMGSTDENQWYRKH] [FLIVAMGSTDENQ-
WYRKH]) (written in the Prosite syntax where [XY] means
amino acid X or Y in that particular position; the supplemented
amino acids are in bold).
Fig. 2. Generation of Oaf1/Pip2 TAD Pattern. (A) Multiple sequence alignment of Oaf1 orthologs and the close paralog Pip2 (MIPS, http://mips.gsf.de/genre/proj/
yeast/index.jsp) resulted in the Oaf1/Pip2 consensus sequence. Two periods indicate continuing sequence. (B) Amino acids are grouped according to their
hydrophobicity values. *The amino acids P and G were omitted to avoid structural breaks in the TADs, and the amino acid C was omitted to avoid S-peptidyl bridging
and chelating amino acid H to avoid presence of ion complexes. (C) The consensus amino acids in each position were supplemented with amino acids from the
corresponding hydrophobicity group. Supplemented amino acids are underlined. (D) The supplementation protocol revealed the general Oaf1/Pip2 pattern.
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A Prosite pattern search (http://www.expasy.ch/prosite/)
using the Oaf1/Pip2 TAD pattern resulted in the identification
of a similar motif (DVYNYLFD, amino acids 862-870) in the
TADof the transcription factor Gal4 (amino acids 842-874) (Fig.
3). Strikingly, the previously reported Gal4 loss-of-function
mutations V864E/L868V and F869A and the C-terminal
truncation of five amino acids were located precisely within
the predicted Oaf1/Pip2 TAD pattern (Fig. 3A) [24,28].To test whether the predicted TAD of Gal4 possesses a
transactivation function, we analysed the critical region (amino
acids 860-871, construct B1, Fig. 3B) for transactivation by
fusing it to LexA in a yeast one-hybrid system. Analogous to
Oaf1, a strong transactivation activitywas found for the predicted
region of Gal4 (construct B1, Fig. 3B) that was comparable to
that of the full-length Gal4 (construct B51, Fig. 3B).
The alignment of Oaf1, Pip2, and Gal4 orthologs (Fig. 3C)
revealed that an additional amino acid (D) is conserved at the
beginning of the Oaf1/Pip2 TAD pattern, and therefore it was
Fig. 3. Identification of 9aa TAD in Gal4. (A) Activity of Gal4 one-hybrid constructs as reported previously [24,28]. The predicted position of the general Oaf1/Pip2
TAD pattern is in bold. (B) The indicated regions of Gal4 comprising the predicted Oaf1/Pip2 TAD pattern were cloned and their activity was confirmed using the one-
hybrid system. (C) The alignment of Gal4, Oaf1, and Pip2 revealed a conserved 9-amino-acid region (9aa TAD) shown in bold. Values represent β-galactosidase
activity of the mutant constructs in percentage of the constructs B1 (means and plusmn; SD; n=3).
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mental and computational approaches, a nine-amino-acid
pattern common to the TADs of the Gal4 family members was
identified (Fig. 3C). This nine-amino-acid-long domain posses-
sing autonomous transcriptional activity was termed 9aa TAD.
Application of the 9aa TAD pattern for prediction
The Oaf1/Pip2 TAD pattern was successfully used for the
identification of the Gal4 9aa TAD (Fig. 3). To derive a general
Gal4 9aa TAD consensus we aligned the known Gal4 orthologs
(Fig. 4A). The Gal4 TAD consensus was combined with the
Oaf1/Pip2 TAD consensus (Fig. 2A) to generate the Oaf1/Pip2/
Gal4 TAD consensus (Fig. 4B). To produce a general Oaf1/
Pip2/Gal4 TAD pattern, the Oaf1/Pip2/Gal4 TAD consensus
was supplemented by amino acids with similar hydrophobicity
values (Fig. 4C) according to the rules described for Fig. 2B.
This approach resulted in the generation of the following Oaf1/
Pip2/Gal4 TAD pattern (the supplemented amino acids are in
bold): [GSTDENQWYRKH] [FLIVAMDENQWY] [FLI-
VAMSTYW] [FLIVAMDENQWY] [FLIVAMGSTDENQ-
WYRKH] [FLIVAMDENQWY] [FLIVAMSTYW ]
[FLIVAMGSTDENQWYRKH] [FLIVAMGSTDENQ-
WYRKH] (Fig. 4D). Our assumptions that were used to
produce this pattern (i.e., addition of amino acids from the same
hydrophobicity group) were further justified by the analysis of
the hydrophobicity profile of the 9aa TAD in individual
transcription factors (Fig. 5B) and the accuracy of the Oaf1/
Pip2/Gal4 TAD pattern in prediction of 9aa TAD (Fig. 5A).The Oaf1/Pip2/Gal4 TAD pattern was used to search for
TADs in other Gal4 family members. The positions of the
predicted TADs in Tea1 and Leu3 correlated well with
experimentally identified TADs reported previously (Fig. 5A)
[23,24,26,28–30]. These data confirm the potential of the Oaf1/
Pip2/Gal4 TAD pattern to predict TADs in other members of the
Gal4 family.
The pattern search also delivered several false-positive hits
located outside of the known TAD. For example, in the Oaf1
sequence the Oaf1/Pip2/Gal4 TAD pattern was found several
times outside of the Oaf1 TAD. This prompted us to increase the
stringency of the search pattern to reduce the number of false-
positive results. To this end, the hydrophobicity profiles of the
identified 9aa TADs (Fig. 5A) were plotted (Fig. 5B) to
determine the general hydrophobicity rules for the 9aa TAD.
The analysis of the hydrophobicity profile resulted in several
modifications in the Oaf1/Pip2/Gal4 TAD pattern. We noticed
that positions p3 and p7 differed from the other positions in that
no hydrophilic amino acids were found in these positions. This
suggested that positions p3 and p7 were involved in hydro-
phobic protein-protein interactions that require amino acids
with large side chains. For this reason we excluded alanine from
positions p3 and p7 because this small amino acid is, despite a
high hydrophobicity value, not favorable for hydrophobic
protein-protein interactions. Moreover, the rather neutral amino
acids S, T, and Y were also left out from positions p3 and p7 to
preserve the hydrophobicity peaks. Position p8 is characterized
by the presence of predominantly hydrophobic amino acids
displaying a hydrophobicity value 1.8 and more. Thus, the
Fig. 4. Generation of Oaf1/Pip2/Gal4 TAD pattern. (A) 9aa Gal4 TAD as revealed by alignment of Gal4 orthologs. (B) The Gal4 and Oaf1/Pip2 consensus sequences
were combined to generate Oaf1/Pip2/Gal4 consensus. (C) Amino acids in each position of the Oaf1/Pip2/Gal4 consensus were supplemented with amino acids from
the corresponding hydrophobicity group (the same hydrophobicity groups were used as in Fig. 2B). Supplemented amino acids are underlined. (D) The
supplementation protocol revealed the general Oaf1/Pip2/Gal4 pattern.
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and T in position p8 were excluded.
The amino acids R, K, and H were excluded from positions
p1 and p9 since they are responsible for 40% of false-positive
results in the Oaf1 9aa TAD prediction. As described for the
Oaf1/Pip2 TAD pattern, proline was omitted from the whole
pattern and glycine was omitted from the internal positions p2-
p7 to avoid structural breaks. Cysteine was excluded to avoid S-
peptidyl bridging. The amino acid M was added to position p1
of the 9aa TAD to reflect its presence in the putative 9aa TAD of
the transcriptional factor Lys14. Using these changes the final
yeast 9aa TAD pattern was derived: [GSTDENQWYM]
{KRHCGP} [FLIVMW] {KRHCGP} {CGP} {KRHCGP}
[FLIVMW] [FLIVAMW] {KRHCP}.
For the online 9aa TAD prediction service (http://www.at.
embnet.org/toolbox/9aatad/) 12 additional refinement criteria,RC1-RC12, were generated, which can be optionally used if too
many 9aa TAD motifs are found in a given sequence. We first
decided to describe the hydrophobicity profile (Fig. 5B) of the
9aa TAD as a whole. To achieve this it was necessary to define
the allowed amino acids at each position but not independent of
the amino acids at other positions (RC1-RC7, Fig. 5C): (1) in
addition to the hydrophobic amino acids at positions p3 and p7
at least one additional hydrophobic amino acid in the region
around these two core hydrophobic positions is required in the
refinement criteria RC1 and RC2; (2) the presence of at least
one hydrophilic amino acid in the region between the two
hydrophobic patches is required in RC3; (3) the total number of
hydrophilic and hydrophobic amino acids in the pattern is
limited by the refinement criteria RC4 and RC5 (amino acids S
and T are included in both refinement criteria); (4) the total
number of consecutive amino acids with similar hydrophobic or
Fig. 5. (A) Identification of 9aa TADs in Gal4 family. List of experimentally localized transactivation domains in the Gal4 family, as reported previously [23,24,26,28–
30] and the predicted 9aa TADs. (B) Hydrophobicity plot for predicted 9aa TADs in the Gal4 family. The hydrophobicity values (arbitrary units) of individual amino
acids were plotted for each position of the 9aa TAD sequence according to [27]. All 9aa TADs comprise two main hydrophobic patches around positions p3 and p7
with an embedded hydrophilic region around position p5. (C) List of refinement criteria for 9aa TAD prediction. Each refinement criterion applies to all highlighted
positions of the 9aa TAD and can be used in online prediction available at http://www.at.embnet.org/toolbox/9aatad/.
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and RC7, respectively. Furthermore, the false-positive predic-
tion results obtained for Oaf1, Pip2, and Gal4 were used to
define the maximal allowed number of the less favorable amino
acids N, Q, R, K, and H in a particular region of the 9aa TAD
pattern (refinement criteria RC8-RC10). Finally, the bridging
amino acid C and the helical-structure breakers P and G are
excluded from the internal 9aa TAD sequence by refinement
criteria RC11-RC12. Refinement criteria RC11 and RC12
reflect the finding that the TADs of several transcription factors
with predicted 9aa TAD display and alpha-helical secondary
structure (e.g. p53, VP16 [3,25,31,32]).
Transcriptional activity of 9aa TAD in mammalian cells
It has been previously reported that the transactivation
domain of Gal4 is universally functional, i.e., it is capable of
transactivating in both yeast and mammalian systems [33].
These observations prompted us to test whether the 9aa TAD of
Oaf1 could transactivate in mammalian cells, similar to the TAD
of Gal4. We fused parts of the Oaf1 TAD to the Gal4 DNA
binding domain and assayed their activity in a mammalian
Gal4-based one-hybrid system. Analogous to the yeast assays,
the construct pM27 containing the 27-amino-acid-long Oaf1
TAD (amino acids 1021-1047), as well as the 13-amino-acid-
long construct pM13 (amino acids 1035-1047) displayed a
strong activity, whereas the 8-amino-acid-long construct pM8
(amino acids 1035-1042) showed a greatly reduced activity
(Fig. 6). Thus, these data show that the 9aa TAD can be
recognized by the transcription machinery in both yeast and
mammalian cells.
9aa TAD pattern prediction outside of the yeast Gal4 family
Since the 9aa TAD of Oaf1 can activate transcription in
mammalian cells we reasoned that the 9aa TAD or a similar
pattern is present in mammalian transcription factors as well.
We first decided to apply the 9aa TAD pattern search on
transcription factors unrelated to the Gal4 family but, however,
conserved in mammals and yeast. In general, yeast and
mammalian transcription factors do not display significantFig. 6. Transactivation of 9aa TAD in a mammalian cell line. The Oaf1 transactivation
pM13, amino acids 1035–1047), and 8 amino acids (construct pM8, amino acids 102
viral transactivator VP16 (positive control) were tested in a one-hybrid assay for tra
induction of CAT normalized to β-galactosidase activity of a cotransfected constitusequence similarities. However, the yeast transcription factor
Rtg3 and the mammalian E2A display an exceptionally high
degree of similarity. Both transcription factors contain a well-
characterized TAD with the critical LDSF sequence in its core
[32,34]. The pattern search resulted in the identification of two
9aa TADs in Rtg3 and a single 9aa TAD in E2A (Fig. 7A).
Importantly, the single 9aa TAD in E2A and the first of the two
9aa TADs in Rtg3 comprise the LDFS sequence and match
exactly with the experimentally determined position of crucial
amino acids reported previously [32,34]. The second 9aa TAD
in Rtg3 is located in a region that has not been well
characterized, thus existence of a TAD at this position cannot
be excluded. An alignment of E2A homologs revealed that the
9aa TAD is conserved among these proteins (Fig. 7B).
A closer inspection of the 9aa TAD in E2A (DLLDFSMMF)
indicated that the last four amino acids displayed a lower degree
of conservation with regard to the 9aa TAD of Oaf1 or Gal4
(DLFDYDFLF and DDVYNYLFD, respectively). To take into
account this divergence we decided to consider the less
conserved amino acids by including them in the yeast 9aa
TAD pattern for search in animal transcription factors. We
modified the yeast 9aa TAD pattern by releasing the positions
p6, p8, and p9 in the pattern to any amino acids except G, P, and
C. The released animal pattern was used for the prediction of the
9aa TAD in several additional transcription factors that contain
experimentally well-characterized TADs. A Prosite pattern
search with the animal 9aa TAD pattern revealed that all these
factors contained 9aa TADs (Fig. 8).
A subgroup of these transcription factors has been reported
to interact with the general transcriptional cofactor TAF9 [1–3].
These transcription factors include VP16, p53, HSF1, NF-IL6,
nuclear factor-κB, and NFAT1. Strikingly, the 9aa TADs of
these transcription factors were localized in a 17-amino-acid
region known to be recognized by TAF9. These results suggest
that the 9aa TAD represents a common pattern that interacts
with TAF9. Although the final yeast and animal 9aa TAD
patterns differ by only a few amino acids (Fig. 7C), for best
results their use in prediction searches should be restricted to
yeast or animal proteins, respectively. To visualize the quality of
the predicted 9aa TADs and to provide a confidence index the
results of the online prediction service are classified into threedomain comprising 27 (construct pM27, amino acids 1035–1042), 13 (construct
1–1047); the empty vector pM0 (negative control); and pM-VP16 containing the
nsactivation abilities in the REF52 rat fibroblast cell line. Values represent fold
tive β-gal expression plasmid (means and plusmn; SD; n=3).
Fig. 7. Prediction of 9aa TAD in yeast Rtg3 and its human ortholog E2A. (A) Using the yeast 9aa TAD pattern [GSTDENQWYM] {KRHCGP} [FLIVMW]
{KRHCGP} {CGP} {KRHCGP} [FLIVMW] [FLIVAMW] {KRHCP} for prediction revealed two 9aa TADs in the yeast Rtg3 and a single 9aa TAD in the human
ortholog E2A. The 9aa TAD in E2A and one of the two 9aa TADs from Rtg3 correspond well with reported amino acids critical for transactivation (underlined and in
bold) [32,34]. (B) The predicted 9aa TADs of the yeast Rtg3 and the mammalian E2A orthologs are aligned. (C) The 9aa TAD patterns for yeast and animals.
764 S. Piskacek et al. / Genomics 89 (2007) 756–768categories according to the overall score compared to the
prototype 9aa TAD. In addition, a graphical view of the
hydrophobicity profile (similar to Fig. 5) is generated for each
hit of the online prediction service.
Discussion
In this study we establish a novel nine-amino-acid pattern
that is conserved in the transactivation domains of a number of
related as well as unrelated transcription factors. This 9aa TAD
functions as an autonomous transactivation domain in both
lower and higher eukaryotes. The identification of the 9aa TAD
was initiated by our search for a minimal transactivation domain
in the previously characterized transactivation domain of Oaf1
[23]. To identify such a minimal transactivation region several
criteria were applied. First, the minimal TAD of Oaf1 must
possess a robust autonomous transactivation function. Second,
the deletion or mutation of this region should cause Oaf1 to lose
the transactivation activity. The highest priority was put on the
shortest possible length, whereas the relative values of
transactivation ranked second to the length of the sequence.
This approach resulted in the identification of a nine-amino-acidregion that displayed transactivation, implying that this short
motif was able to recruit the transcription machinery. A further
shortening of the 9aa TAD resulted in a complete loss of
activity. The addition of several amino acids on either side of
this 9aa TAD increased its transcription activity. However, since
these additional amino acids are not conserved in the Oaf1
orthologs we classified these residues as flanking amino acids.
As nonessential and nonconserved amino acids these flanking
amino acids were not included in the pattern. The significance
of the 9aa TAD was further confirmed by our finding that the
9aa TAD displayed transactivation activity on both yeast and
mammalian cells and with two different DNA binding modules
(Gal4 and LexA).
To derive the pattern that could be used for the identification
of the 9aa TAD in other transcription factors we proceeded
stepwise from the alignment of the Oaf1 orthologs, to
generation of 9aa TAD, to prediction of a 9aa TAD in Gal4,
to experimental evidence for the presence of a 9aa TAD in Gal4,
to the final refinement criteria suitable to detect 9aa TAD in
many diverse yeast and animal transcription factors. The final
refinement procedure is recommended for a more accurate
prediction of the 9aa TAD in cases in which the search with the
Fig. 8. Prediction of 9aa TAD in transcription factors. The predicted 9aa TADs correlate with reported positions of TADs [1–3,10,11,25,31,41,42,46–55]. The
relevance of the predicted 9aa TADs for transactivation is confirmed by colocalization of 9aa TADwith reported loss-of-function mutations (small letters). The regions
known to interact with the general transcriptional cofactor TAF9 overlap with the predicted 9aa TADs (amino acids involved in the TAF9 interactions are underlined).
765S. Piskacek et al. / Genomics 89 (2007) 756–768plain 9aa TAD pattern generates more than one hit per sequence.
Thus, the refinement criteria can reduce the number of false-
positive results. The 9aa TAD sequence itself can sustain various
point mutations without detectable changes in activity (data not
shown). Onlymore severe interventions, such as the exchange ofthree central amino acids, result in a loss-of-function mutation.
This enormous variability of the 9aa TAD is in line with
experiments showing a pronounced insensitivity of the transac-
tivation domains to mutagenesis [4,8]. The highly diverse nature
of 9aa TAD explains why the characterization of a common TAD
766 S. Piskacek et al. / Genomics 89 (2007) 756–768pattern has met with relatively little success. The identified
TADs display no obvious sequence similarity, with the
exception of accumulation of acidic and hydrophobic residues
[4,7,35]. Also, structural studies did not reveal common
structural motifs in several exemplary acidic TADs [36–38].
Despite of the lack of detectable similarities, the TADs of the
transcription factors Gal4 and Gcn4 were found to interact with
same transcription cofactors [39,40]. Remarkably, a functional
9aa TAD is present in the TADs of both Gal4 and Gcn4,
suggesting that the 9aa TAD represents a minimal region
required for the interactions with the general transcriptional
cofactors. In addition to the Gal4 family, we found the 9aa
TADs in the unrelated yeast transcription factor Rtg3 and its
human ortholog E2A. The TADs of both transcription factors
are reported to contain an LDFS activation motif [32,34], which
is in the core of the 9aa TAD pattern. These findings indicate
that the 9aa TAD is present as an essential subdomain in the
TADs of a variety of otherwise unrelated transcription factors.
For improved prediction accuracy the yeast 9aa TAD pattern
should be used for yeast, whereas the animal 9aa TAD pattern is
recommended for all higher eukaryotes. The differentiation
between yeast and animal sequences is often required due to the
considerable evolutionary distance between yeast and animals
(e.g., subcellular localization of proteins using PSORT, http://
psort.ims.u-tokyo.ac.jp/form2.html).
The usefulness of the 9aa TAD pattern is further demon-
strated by the presence of a 9aa TAD in the transcription factors
VP16, p53, HSF1, NF-IL6, nuclear factor-κB, and NFAT1,
which, despite no obvious sequence similarity, all bind to the
general transcriptional coactivator TAF9. Importantly, where
characterized, the position of the TAF9-binding domain
corresponds to the position of the predicted 9aa TAD. In the
case of p53, which is known to possess two transactivation
domains, TADI and TADII [41], a Prosite search for 9aa TAD
results in the identification of three putative 9aa TADs. The first
9aa TAD (amino acids 17-25) is located in TADI and matches
exactly with a region shown to contain amino acids essential for
transactivation (amino acids L22 and W23) [42]. Notably, the
sequence of the loss-of-function mutation L22Q/W23S [42]
does not match the 9aa TAD criteria any more and is not found
in the 9aa TAD search. This region of p53 has been reported to
mediate the interaction with the general transcriptional
coactivator TAF9 [1]. The second putative 9aa TAD of p53 is
located in TADII (amino acids 43-73) and correlates with the
position of another loss-of-function mutation, W53Q/F54S
[41]. This example reveals the potential of the 9aa TAD pattern
to predict not only the presence and position of a TAD, but also
the possible interaction molecules. In a similar manner we
propose a number of other transcription factors to contain 9aa
TADs in positions that have been proven by loss-of-function
mutation to be essential for activity (data not shown, see online
http://www.at.embnet.org/toolbox/9aatad/).
Results from our studies as well as other currently available
published data confirm the existence of a widespread 9aa TAD
family. The prediction service is now available online at http://
www.at.embnet.org/toolbox/9aatad/, the European Molecular
Biology Network (EMBnet) node Austria. Similar to mostpattern search engines, the 9aa TAD prediction service can
deliver false-positive results or it may miss true 9aa TADs.
Given the rather low requirements on the sequence it is clear
that 9aa TADs can be found also in proteins other than
transcription factors. Thus, a global search for transactivation
domains using the 9aa TAD pattern is not advisable. As
discussed above, the refinement criteria represent a useful tool
to adjust the stringency of the 9aa TAD search. We anticipate
further studies and retrospective reports to identify transactiva-
tion domains identical to, similar to, or different from the 9aa
TAD family. These studies will generate the basis for additional
improvement and refinement of the 9aa TAD pattern and the
prediction utilities.
Materials and methods
Yeast strains, media, and cloning procedures
Transformants of yeast strain L40 [43] were selected and grown on minimal
medium with 0.67% YNB without amino acids (Difco), 2% glucose, and amino
acid supplements as required. All yeast LexA one-hybrid constructs [43] were
prepared by cloning PCR inserts (Supplementary Fig. 1 and [23]) with EcoRI
and PstI into the pBTM116 vector [43]. The yeast LexA constructs B6, B12, and
B14 were converted into mammalian Gal4bd one-hybrid constructs by cloning
the inserts of the pBTM116-derived plasmids into the pM vector (Clontech)
using EcoRI and PstI.
Assessment of enzyme activities in yeast
β-Galactosidase activity was determined in the yeast crude extracts using the
o-nitrophenyl- β-d-galactoside assay [44]. The average value of β-galactosidase
activities from at least three experiments is presented with standard errors.
β-Galactosidase activities were comonitored on YPD X-gal plates.
CAT assays
The REF52 rat fibroblasts were grown in DMEM supplemented with 10%
fetal calf serum at 37 and deg;C and 7.5% CO2. The cells were transfected with
1.5 μg of pG5-CAT, 0.5 μg of pCMV β-gal, and 1.5 μg of pM vector. Extracts
from cells harvested 24 h after transfection were used in CAT-ELISA (Roche)
according to the manufacturer's protocol and normalized for transfection
efficiency by β-galactosidase activity assay.
Computational analysis
Pattern search was done using the online ScanProsite Pattern searching tool
on the PROSITE home page (http://www.expasy.ch/tools/scanprosite/) accord-
ing to the PROSITE guidelines [45].Acknowledgments
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